—

Octagon Capital Advisors LP

Q1 2026 13F Holdings

  • Location
    new york, NY
  • Num holdings

    29

  • Value ($000)

    $903,606

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001839435
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
D
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$163.36M
18 %

1,946,667

C
COGT

COGENT BIOSCIENCES INC

COM
19240Q201
$90.45M
10 %

2,350,000

---

ABIVAX SA

SPONSORED ADS
00370M103
$75.38M
8 %

677,000

A
ALMS

ALUMIS INC

COM
022307102
$62.36M
7 %

2,830,700

---

DEFINIUM THERAPEUTICS INC

COM SHS
24477V105
$46.12M
5 %

2,440,000

A
AVBP

ARRIVENT BIOPHARMA INC

COM
04272N102
$45.47M
5 %

1,971,054

T
TSHA

TAYSHA GENE THERAPIES INC

COM SHS
877619106
$39.6M
4 %

8,859,911

K
KYMR

KYMERA THERAPEUTICS INC

COM
501575104
$35.4M
4 %

425,000

M
MIRM

MIRUM PHARMACEUTICALS INC

COM
604749101
$31.31M
4 %

338,900

---

BIOAGE LABS INC

COM
09077V100
$30.57M
3 %

1,748,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 29